VJHemOnc Podcast

VJHemOnc Podcast

Por: VJHemOnc
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
200 episodios disponibles

Latest episodes of the podcast VJHemOnc Podcast

Mostrando página 5 de 10

Monoclonal B-cell lymphocytosis: classification, biology and exploring the possibility of early interception 22/03/2024
The impact of CAR-T therapy on the myeloma treatment landscape, patient selection for CAR-T & the evolving role of autoSCT 15/03/2024
Diagnosing amyloidosis, currently available therapies & the importance of cardio-oncology 07/03/2024
Addressing the importance of lymphodepletion, factors contributing to ICAHT & the cost effectiveness of CAR-T therapy 29/02/2024
Updates with the use of CAR-T therapy in ALL: ongoing challenges, strategies to overcome resistance & future outlooks 22/02/2024
Targeted therapy in AML: the growing role of menin inhibitors & clinical trials exploring these agents 16/02/2024
Updates in lower- and higher-risk MDS: challenges, novel agents & key clinical trials at ASH 2023 08/02/2024
Key updates in thalassemia at ASH 2023: gene therapies, ongoing trials & the value of precision medicine 31/01/2024
Updates, challenges and novel agents being explored in BPDCN 25/01/2024
Unanswered questions regarding the sequencing of BCMA therapies, the prognostic value of CTCs & the growing role of quadruplets 18/01/2024
Key updates in sickle cell disease at ASH 2023: disease biology, ongoing trials & the growing role of gene therapy 12/01/2024
ASH 2023 highlights: updates in the diagnosis and treatment of amyloidosis 05/01/2024
MPN highlights at ASH 2023: novel agents & ongoing clinical trials in ET, PV and MF 22/12/2023
iwNHL 2023 Session V: Expanding the CAR platform in NHL 15/12/2023
iwCLL 2023: The role of continuous BTKis, approaching Richter’s transformation & addressing the underrepresentation of elderly patients in trials 07/12/2023
iwNHL 2023 Session IV: Novel therapies in NHL: BTK inhibitors, BTK degraders, and bispecific antibodies 01/12/2023
Unmet needs in AL amyloidosis, novel treatment strategies being explored, and the role of CHIP 24/11/2023
iwNHL 2023 Session III: Recent updates with the use of antibody-drug conjugates in NHL 17/11/2023
MPN diagnosis & treatment: novel agents in PV, clinical guidance for the use of JAK inhibitors & the growing role of combination approaches 10/11/2023
iwNHL 2023 Session II: The evolving treatment landscape in mantle cell lymphoma 03/11/2023
« Primera ‹ Anterior 1 ... 3 4 5 6 7 ... 10 Siguiente › Última »
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA